OverviewSuggest Edit

Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices. It offers pacemakers, defibrillators, remote patient monitring and diagnostic monitoring solutions, spinal cord stimulator systems, a range of catheters, CTO systems, direct visualization systems, fiducial markers, forceps, guidewires, lasers, fibers, lifting agents, needles, penile prosthesis, retrieval devices, slings, snares, stents, ureterosopes, vein ablation solutions, thrombectomy systems, sphincterotomes, etc.
TypePublic
Founded1979
HQMarlborough, MA, US
Websitebostonscientific.com
Employee Ratings4.3
Overall CultureA+

Latest Updates

Employees (est.) (Dec 2020)38,000(+6%)
Job Openings1,158
Revenue (FY, 2020)$9.9 B(-7%)
Share Price (Jun 2021)$43.6(+2%)
Cybersecurity ratingCMore

Key People/Management at Boston Scientific

Michael F. Mahoney

Michael F. Mahoney

Chairman, Chief Executive Officer
Daniel J. Brennan

Daniel J. Brennan

Executive Vice President and Chief Financial Officer
Desiree Ralls-Morrison

Desiree Ralls-Morrison

Senior Vice President, General Counsel and Corporate Secretary
Edward MacKey

Edward MacKey

Executive Vice President, Global Operations
Art Butcher

Art Butcher

Executive Vice President and President, Asia Pacific
Wendy Carruthers

Wendy Carruthers

Senior Vice President, Human Resources
Show more

Boston Scientific Office Locations

Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 21 other locations
Marlborough, MA, US (HQ)
300 Boston Scientific Way, Marlborough
Arden Hills, MN, US
4100 Hamline Ave N
Maple Grove, MN, US
1 Scimed Pl
San Jose, CA, US
150 Baytech Dr
Santa Clarita, CA, US
25155 Rye Canyon Loop, Valencia
Spencer, IN, US
780 Brookside Dr
Show all (26)

Boston Scientific Financials and Metrics

Boston Scientific Revenue

Embed Graph
View revenue for all periods
Boston Scientific's revenue was reported to be $9.91 b in FY, 2020 which is a 7.7% decrease from the previous period.
USD

Revenue (Q1, 2021)

2.8b

Gross profit (Q1, 2021)

1.9b

Gross profit margin (Q1, 2021), %

67.5%

Net income (Q1, 2021)

341.0m

EBIT (Q1, 2021)

370.0m

Market capitalization (21-Jun-2021)

61.1b

Closing stock price (21-Jun-2021)

43.6

Cash (31-Mar-2021)

2.0b

EV

68.2b
Boston Scientific's current market capitalization is $61.1 b.
Annual
USDFY, 2018FY, 2019FY, 2020

Revenue

9.8b10.7b9.9b

Revenue growth, %

9%9%(8%)

Cost of goods sold

2.8b3.1b3.5b

Gross profit

7.0b7.6b6.4b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Revenue

2.5b2.6b2.7b2.5b2.0b2.7b2.8b

Cost of goods sold

730.0m758.0m777.0m806.0m791.0m869.0m894.0m

Gross profit

1.8b1.9b1.9b1.7b1.2b1.8b1.9b

Gross profit Margin, %

71%71%71%68%61%67%68%
Annual
USDFY, 2018FY, 2019FY, 2020

Cash

146.0m217.0m1.7b

Accounts Receivable

1.6b1.8b1.5b

Inventories

1.2b1.6b1.4b

Current Assets

4.0b4.7b6.7b
Quarterly
USDQ1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Cash

139.0m123.0m277.0m370.0m1.7b2.0b2.0b

Accounts Receivable

1.6b1.7b1.8b1.6b1.5b1.6b1.6b

Inventories

1.2b1.3b1.6b1.6b1.5b1.5b1.4b

Current Assets

6.2b6.3b4.8b4.8b5.8b6.2b6.1b
Annual
USDFY, 2017FY, 2018FY, 2019FY, 2020

Net Income

104.0m1.7b4.7b(82.0m)

Depreciation and Amortization

844.0m894.0m1.0b1.1b

Inventories

(107.0m)(83.0m)(290.0m)(65.0m)

Accounts Payable

195.0m(631.0m)111.0m88.0m
Quarterly
USDQ1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021

Net Income

298.0m853.0m1.3b424.0m578.0m704.0m11.0m341.0m

Depreciation and Amortization

268.0m

Inventories

(115.0m)

Accounts Payable

(10.0m)
Show all financial metrics

Boston Scientific Operating Metrics

FY, 2018FY, 2019FY, 2020

Countries

130120120

Medical Institutions Covered (U.S.)

35 k37 k35 k

Patent Applications

5 k6 k6 k

Patents Issued

19 k21 k18 k
Show all operating metrics

Boston Scientific Acquisitions / Subsidiaries

Company NameDateDeal Size
Lumenis Surgical DivisionMarch 03, 2021$1.1 b
Preventice SolutionsJanuary 21, 2021$925 k
FarapulseSeptember 21, 2020
VertiFlexMay 09, 2019$465 m
BTGNovember 19, 2018$4.2 b
AugmenixSeptember 10, 2018$600 m
VenitiAugust 08, 2018$160 m
Claret MedicalJuly 20, 2018$270 m
Cryterion MedicalJuly 05, 2018
nVision MedicalApril 12, 2018$275 m
Show more

Boston Scientific Revenue Breakdown

Embed Graph

Boston Scientific revenue breakdown by business segment: 30.9% from MedSurg, 27.8% from Rhythm Management, 39.1% from Cardiovascular and 2.2% from Other

Boston Scientific revenue breakdown by geographic segment: 42.5% from Other Countries and 57.5% from U.S.

Human Capital Metrics

Embed Graph
Show all human capital metrics

Boston Scientific Cybersecurity Score

Cybersecurity ratingPremium dataset

C

78/100

SecurityScorecard logo

Boston Scientific Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

60-79

out of 100

CSRHub logo

Boston Scientific Online and Social Media Presence

Embed Graph

Boston Scientific Company Culture

  • Overall Culture

    A+

    77/100

  • CEO Rating

    A+

    88/100

  • Compensation

    A

    80/100

  • Diversity

    A-

    76/100

Learn more on Comparably

Boston Scientific News and Updates

Here’s Why Boston Scientific Is Undervalued At $43 Levels

We believe that the stock price of ​Boston Scientific (NYSE: BSX) is undervalued at current levels of $43. BSX stock is up 65% from the levels of around $26 it was at on March 23, 2020, underperforming the broader markets with the S&P 500 rising 89% over the same period...

Global Medical Implants Market (2021 to 2029) - Featuring Abbott Laboratories, Boston Scientific and Stryker Among Others

Dublin, June 17, 2021 (GLOBE NEWSWIRE) -- The "Medical Implants Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering. Changes in therapeutic scie…

Global Medical Electrodes Market (2021 to 2029) - Featuring GE Healthcare, Boston Scientific and 3M Healthcare Among Others

Dublin, June 15, 2021 (GLOBE NEWSWIRE) -- The "Medical Electrodes Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2021 to 2029" report has been added to ResearchAndMarkets.com's offering. The global medical electr…

Worldwide Vascular Stents Industry to 2026 - Featuring Medtronic, Abbott Laboratories and Boston Scientific Among Others

Dublin, June 14, 2021 (GLOBE NEWSWIRE) -- The "Vascular Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global vascular stents market reached a value of US$ 9.4 Billion in 2020. A vascul…

Insights on the Microwave Ablation Global Market to 2027 - Featuring Angio Dynamics, Boston Scientific and Med Waves Among Others

Dublin, June 04, 2021 (GLOBE NEWSWIRE) -- The "Microwave Ablation - Global Market Trajectory & Analytics" report has been added to ResearchAndMarkets.com's offering. Amid the COVID-19 crisis, the global market for Microwave Ablation estimated at US$132.8 Million in the year 2020, is projected …

Boston Scientific Completes CE Mark for EXALT™ Model B Single-Use Bronchoscope

Company to begin limited market release in Europe in June MARLBOROUGH, Mass., May 25, 2021 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has completed CE Mark for the EXALT™ Model B Single-Use Bronchoscope, a single-use device designed for bedside procedures...
Show more

Boston Scientific Blogs

Boston Scientific Receives FDA Approval for TheraSphere™ Y-90 Glass Microspheres

Treatment is the only radioembolization treatment approved for U.S. patients with hepatocellular carcinoma

Boston Scientific Launches WaveWriter Alpha™ Spinal Cord Stimulator Systems In U.S.

SCS portfolio features largest portfolio of full-body MRI conditional devices that combine therapy options for personalized pain relief
Show more

Boston Scientific Frequently Asked Questions

  • When was Boston Scientific founded?

    Boston Scientific was founded in 1979.

  • Who are Boston Scientific key executives?

    Boston Scientific's key executives are Michael F. Mahoney, Daniel J. Brennan and Desiree Ralls-Morrison.

  • How many employees does Boston Scientific have?

    Boston Scientific has 38,000 employees.

  • What is Boston Scientific revenue?

    Latest Boston Scientific annual revenue is $9.9 b.

  • What is Boston Scientific revenue per employee?

    Latest Boston Scientific revenue per employee is $260.9 k.

  • Who are Boston Scientific competitors?

    Competitors of Boston Scientific include Merit Medical Systems, Integer Holdings and Johnson & Johnson.

  • Where is Boston Scientific headquarters?

    Boston Scientific headquarters is located at 300 Boston Scientific Way, Marlborough, Marlborough.

  • Where are Boston Scientific offices?

    Boston Scientific has offices in Marlborough, Arden Hills, Maple Grove, San Jose and in 21 other locations.

  • How many offices does Boston Scientific have?

    Boston Scientific has 26 offices.